When it comes to treating nasal and pharyngeal plasmacytoma (an extramedullary plasmacytoma, or EMP), radiation therapy is the go-to standard treatment. It works really well because EMP is highly sensitive to radiation, with success rates around 90%.
The choice between photon and proton radiation is an important one Show Full Answer
When it comes to treating nasal and pharyngeal plasmacytoma (an extramedullary plasmacytoma, or EMP), radiation therapy is the go-to standard treatment. It works really well because EMP is highly sensitive to radiation, with success rates around 90%.
The choice between photon and proton radiation is an important one, especially for tumors in the head and neck region. Here's a general comparison to help guide a conversation with your care team:
Photon Radiation (traditional X-ray based)
- Most widely available
- Well-established for treating EMP in the upper respiratory tract
- Can affect surrounding healthy tissue as the beam passes through
Proton Radiation
- More precisely targets the tumor, reducing radiation to surrounding healthy tissue
- Particularly beneficial for head and neck tumors near sensitive structures (eyes, brain, spinal cord)
- May reduce long-term side effects in delicate areas like the nasal cavity and throat
- Less widely available
Common side effects of radiation in this area can include fatigue, swelling, nausea, and skin irritation, typically resolving within 6–12 months.
Since plasmacytomas are rare, clinical trial data comparing the two approaches specifically for EMP is limited. This makes it especially important to discuss both options with a specialist, ideally at a center experienced in treating plasma cell tumors.
July 9
Join
Your Privacy Choices
